Kangstem Biotech Co., Ltd. (KOSDAQ:217730)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,712.00
-51.00 (-2.89%)
At close: Nov 16, 2026

Kangstem Biotech Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
161,021218,206113,229133,971109,830124,057
Market Cap Growth
11.97%92.71%-15.48%21.98%-11.47%-36.85%
Enterprise Value
142,796199,99595,018129,76185,183115,828
Last Close Price
1712.002320.001689.512003.152103.332375.78

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
53.0661.0814.6210.556.7410.00
PB Ratio
2.853.162.622.672.081.74
P/TBV Ratio
4.024.182.682.822.271.85

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
47.0655.9812.2710.215.239.34

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.160.140.200.270.250.20
Net Debt / Equity Ratio
-0.32-0.42-0.23-0.47-0.44-0.60
Net Debt / EBITDA Ratio
1.061.910.851.261.402.26
Net Debt / FCF Ratio
1.072.360.501.331.191.97
Asset Turnover
-0.050.110.160.180.13
Inventory Turnover
-3.264.7621.1618.5717.37
Quick Ratio
3.574.752.922.072.733.38
Current Ratio
3.965.253.692.553.223.80
Return on Equity (ROE)
--18.65%-15.18%-45.17%-32.55%-36.40%
Return on Assets (ROA)
--16.06%-13.52%-17.59%-13.99%-15.31%
Return on Capital Employed (ROCE)
-31.60%-24.10%-30.80%-36.40%-31.00%-26.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-7.65%-4.80%-6.77%-16.38%-18.43%-17.21%
FCF Yield
-10.56%-5.65%-17.29%-13.35%-17.82%-17.43%
Buyback Yield / Dilution
-63.45%-24.08%-37.93%-7.02%-36.23%-24.89%